DK0792152T3 - Fremgangsmåder til svangerskabsforebyggelse - Google Patents

Fremgangsmåder til svangerskabsforebyggelse

Info

Publication number
DK0792152T3
DK0792152T3 DK95940773T DK95940773T DK0792152T3 DK 0792152 T3 DK0792152 T3 DK 0792152T3 DK 95940773 T DK95940773 T DK 95940773T DK 95940773 T DK95940773 T DK 95940773T DK 0792152 T3 DK0792152 T3 DK 0792152T3
Authority
DK
Denmark
Prior art keywords
progestogen
period
effective amount
progesterone
time
Prior art date
Application number
DK95940773T
Other languages
English (en)
Inventor
Darcy V Spicer
Malcolm Cecil Pike
John R Daniels
Original Assignee
Balance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Balance Pharmaceuticals Inc filed Critical Balance Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0792152T3 publication Critical patent/DK0792152T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
DK95940773T 1994-11-22 1995-11-21 Fremgangsmåder til svangerskabsforebyggelse DK0792152T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34338394A 1994-11-22 1994-11-22

Publications (1)

Publication Number Publication Date
DK0792152T3 true DK0792152T3 (da) 2004-07-12

Family

ID=23345902

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95940773T DK0792152T3 (da) 1994-11-22 1995-11-21 Fremgangsmåder til svangerskabsforebyggelse

Country Status (9)

Country Link
US (1) US6225298B1 (da)
EP (2) EP0792152B1 (da)
AT (1) ATE264106T1 (da)
CA (1) CA2205897A1 (da)
DE (1) DE69532894T2 (da)
DK (1) DK0792152T3 (da)
ES (1) ES2218556T3 (da)
PT (1) PT792152E (da)
WO (1) WO1996015794A1 (da)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19531936A1 (de) * 1995-08-17 1997-02-20 Schering Ag Kombinationspräparat zur Kontrazeption, Kits diese enthaltend und eine Methode diese verwendend
US6506390B2 (en) 1996-06-25 2003-01-14 Akzo Nobel Progestogen-anti-progestogen regimens
CA2255863A1 (en) * 1996-06-25 1997-12-31 Akzo Nobel Nv Progestogen-anti-progestogen regimens
WO1999025360A2 (en) * 1997-11-14 1999-05-27 Akzo Nobel N.V. Progestogen-antiprogestogen regimens
US6541463B1 (en) * 1998-03-11 2003-04-01 Endorecherche, Inc. Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use
US6667299B1 (en) * 2000-03-16 2003-12-23 Hollis-Eden Pharmaceuticals, Inc. Pharmaceutical compositions and treatment methods
US6509334B1 (en) 1999-05-04 2003-01-21 American Home Products Corporation Cyclocarbamate derivatives as progesterone receptor modulators
US6329416B1 (en) * 1999-05-04 2001-12-11 American Home Products Corporation Combination regimens using 3,3-substituted indoline derivatives
WO2000066168A1 (en) * 1999-05-04 2000-11-09 American Home Products Corporation Compositions containing benzimidazolones and progestogens
US6355648B1 (en) 1999-05-04 2002-03-12 American Home Products Corporation Thio-oxindole derivatives
US6358948B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Quinazolinone and benzoxazine derivatives as progesterone receptor modulators
US6417214B1 (en) 1999-05-04 2002-07-09 Wyeth 3,3-substituted indoline derivatives
US6391907B1 (en) 1999-05-04 2002-05-21 American Home Products Corporation Indoline derivatives
US6380178B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Cyclic regimens using cyclocarbamate and cyclic amide derivatives
US6339098B1 (en) 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6319912B1 (en) * 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
US6444668B1 (en) 1999-05-04 2002-09-03 Wyeth Combination regimens using progesterone receptor modulators
US6407101B1 (en) 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
US6358947B1 (en) 1999-05-04 2002-03-19 American Home Products Corporation Tetracyclic progesterone receptor modulator compounds and methods
ATE275973T1 (de) * 1999-05-04 2004-10-15 Wyeth Corp Empfängnisverhütende zusammensetzungen die progestagen und progesteronantagonisten enthalten
US6399593B1 (en) 1999-05-04 2002-06-04 Wyeth Cyclic regimens using cyclic urea and cyclic amide derivatives
US6462032B1 (en) 1999-05-04 2002-10-08 Wyeth Cyclic regimens utilizing indoline derivatives
US6306851B1 (en) 1999-05-04 2001-10-23 American Home Products Corporation Cyclocarbamate and cyclic amide derivatives
US6380235B1 (en) 1999-05-04 2002-04-30 American Home Products Corporation Benzimidazolones and analogues
US6369056B1 (en) 1999-05-04 2002-04-09 American Home Products Corporation Cyclic urea and cyclic amide derivatives
US6423699B1 (en) 1999-05-04 2002-07-23 American Home Products Corporation Combination therapies using benzimidazolones
US6498154B1 (en) 1999-05-04 2002-12-24 Wyeth Cyclic regimens using quinazolinone and benzoxazine derivatives
UA73119C2 (en) 2000-04-19 2005-06-15 American Home Products Corpoir Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors
DE10045380A1 (de) * 2000-09-14 2002-04-04 Schering Ag Verfahren zur Kontrazeption und dessen Darreichungsform
US6960337B2 (en) * 2002-08-02 2005-11-01 Balance Pharmaceuticals, Inc. Methods and compositions for treating benign gynecological disorders
US7029657B2 (en) 2002-08-02 2006-04-18 Balance Pharmaceuticals, Inc. Nasal spray steroid formulation and method
US6958142B2 (en) 2002-08-02 2005-10-25 Balance Pharmaceuticals, Inc. Nasal spray formulation and method
CN1845723B (zh) * 2003-09-03 2010-07-21 迷斯康贸易有限公司 子宫内膜异位症的治疗方法
CA2537702C (en) * 2003-09-03 2012-01-03 Miscon Trading S.A. Methods for the treatment of endometriosis
EP1761231A1 (en) * 2004-06-07 2007-03-14 Duramed Pharmaceuticals, Inc. Dispenser for progestin used for acute and maintenance treatment of dub
DE102006054535A1 (de) * 2006-11-15 2008-05-21 Bayer Schering Pharma Aktiengesellschaft Progesteronrezeptorantagonisten
US20100204146A1 (en) * 2007-09-17 2010-08-12 Preglem S.A. Treatment of Oestrogen Dependant Conditions in Pre-menopausal Women
DE102009034367A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de) 2009-07-20 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de) 2009-07-21 2011-02-10 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de) 2009-07-21 2011-01-27 Bayer Schering Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102010007719A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
DE102010007722A1 (de) 2010-02-10 2011-08-11 Bayer Schering Pharma Aktiengesellschaft, 13353 Progesteronrezeptorantagonisten
EP2566482A1 (en) * 2010-05-07 2013-03-13 Institut National de la Santé et de la Recherche Médicale Progesterone receptor antagonists and uses thereof
DE102011004899A1 (de) 2011-03-01 2012-09-06 Bayer Pharma Aktiengesellschaft 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
EP3384930A1 (en) 2013-03-15 2018-10-10 AbbVie Inc. Compositions for use in treating heavy menstrual bleeding
SG11201507935TA (en) 2013-04-11 2015-10-29 Bayer Pharma AG Progesterone receptor antagonist dosage form
EP3781167A4 (en) 2018-04-19 2022-02-23 Abbvie Inc. METHOD OF TREATMENT OF HEAVY MENSTRUAL BLEEDING

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH442293A (de) 1963-05-06 1967-08-31 Ciba Geigy Verfahren zur Herstellung neuer Verbindungen der Androstanreihe
DE1643018B2 (de) 1967-04-05 1976-02-19 Schering Ag, 1000 Berlin Und 4619 Bergkamen 4-chlor-1,2 alpha-methylen-delta hoch 4,6- pregnadien-17 alpha-ol-3,20- dion und dessen 17-ester, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE1643027B2 (de) 1967-06-09 1977-12-08 Schering Ag, 1000 Berlin Und 4619 Bergkamen 4,6-dichlor-delta hoch 4,6- steroide der pregnanreihe
US3541137A (en) 1968-02-27 1970-11-17 American Cyanamid Co D-homo-b-nor-estrienes
FR2081560B1 (da) 1970-03-03 1973-04-06 Roussel Uclaf
US3818093A (en) 1971-05-10 1974-06-18 Ortho Pharma Corp Method of inducing infertility and preventing littering in the female
DE2818164A1 (de) 1978-04-21 1979-10-31 Schering Ag 1,3-dibenzoesaeureester des 17alpha- ethinyl-7 alpha -methyl-1,3,5(10)-oestratrien- 1,3,17 beta -triols, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
IL68222A (en) 1983-03-24 1987-02-27 Yeda Res & Dev Contraceptive compositions comprising a progesterone antagonist and a blocker of progesterone activity
US4753794A (en) 1986-06-24 1988-06-28 The General Hospital Corporation Use of mullerian inhibiting substance as a contraceptive agent
WO1993021926A1 (en) * 1992-05-06 1993-11-11 Medical College Of Hampton Roads Minimizing progestin associated breakthrough bleeding
DE4344462C2 (de) * 1993-12-22 1996-02-01 Schering Ag Zusammensetzung für die Empfängnisverhütung
ZA949929B (en) * 1993-12-23 1995-08-23 Akzo Nobel Nv Sugar-coated pharmaceutical dosage unit.
DE4411585A1 (de) * 1994-03-30 1995-10-05 Schering Ag Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption

Also Published As

Publication number Publication date
DE69532894T2 (de) 2004-09-02
EP0792152B1 (en) 2004-04-14
PT792152E (pt) 2004-07-30
EP1488794A3 (en) 2005-04-20
US6225298B1 (en) 2001-05-01
ATE264106T1 (de) 2004-04-15
EP1488794A2 (en) 2004-12-22
EP0792152A1 (en) 1997-09-03
ES2218556T3 (es) 2004-11-16
WO1996015794A1 (en) 1996-05-30
EP0792152A4 (en) 2001-05-09
CA2205897A1 (en) 1996-05-30
DE69532894D1 (de) 2004-05-19

Similar Documents

Publication Publication Date Title
DK0792152T3 (da) Fremgangsmåder til svangerskabsforebyggelse
ATE158717T1 (de) Verfahren und formulierungen zur kontrazeption und zur behandlung von benignen gynäkologischen störungen
KR970706805A (ko) 경피흡수첩부제(percutaneously absorbable patch)
PL182544B1 (pl) Zestaw do antykoncepcji hormonalnej
KR880701553A (ko) 폐경기 전의 여성용 혼합 투약형
NZ234051A (en) Treating post-menopausal disorders using an estrogenic compound mixed with a compound having progestational activity
RU94046068A (ru) Применение конкурентных антагонистов прогестерона для контрацепции, новые соединения ряда конкурентных антагонистов прогестерона
HK1054332A1 (zh) 具有全身效應的新型局部雌激素孕激素組合物
NO845194L (no) Flertrinnskombinasjonspreparat og anvendelse av dette som oralt antikonsepsjonsmiddel
HUP0300335A2 (hu) 8béta-hidrokarbil-szubsztituált ösztratriének mint szelektív hatású ösztrogének, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
YU54602A (sh) Drospirenon za terapiju zamene hormona
DE3888269T2 (de) Hormon-Zusammensetzung und -Anwendung.
NL990003I1 (nl) Anticonceptiemiddel op basis van alleen progestogeen.
KR970704451A (ko) 기능부전성 자궁출혈 치료용 약제의 제조에 유용한 프로게스테론 길항제(Progesterone Antagonists Useful for Preparing Medicaments for Treating Dysfunctional Uterine Bleeding)
CA2561839C (en) Multi-phase contraceptive preparation based on a natural estrogen
AU707235B2 (en) Competitive progesterone antagonists for demand-oriented female birth control
NZ334876A (en) Hormonal composition consisting of an estrogenic derivative and a progestative agent
BR0014161A (pt) Mesoprogestinas (moduladores de receptor de progesterona) no tratamento e prevenção de distúrbios ginecológicos dependentes de hormÈnio benigno
RU1789216C (ru) Состав, обладающий контрацептивным действием
Webb Gestagens, danazol and antiprogestogen in emergency contraception
Wood Hormonal contraception: current perspectives. Part I. An analysis of available agents
NO974255L (no) Preparat for injeksjon én gang pr. måned og som er anvendbart som depot-befruktningshemmende middel og i hormon-erstatningsterapi for perimenopausale og premenopausale kvinner
Deghenghi Steroid Hormones and Their Antagonists
BR0010070A (pt) Uso de org 33245, kit contraceptivo, meio combinado para a dosagem de um progestogênio e um antiprogestogênio, e, métodos de contracepção, e de tratamento de sangramento uterino irregular ou de ruptura em uma fêmea utilizando uma preparação somente de progestogênio
d'Arcangues Once-a-month injectable contraceptives